Author:
Zhao Li,Yang Zhongfeng,Zhou Yan,Liu Yuping,Luo Qiuping,Jiang Qingping,Wang Hui,Wang Na
Abstract
AbstractSclerosing stromal tumors of the ovary are benign and tend to occur in youthful women with lobular structures at low frequencies. Three types of cells, including luteinized cells, short spindle myoid cells, and intermediate cells, are found in the lobules which abundant in the blood vessels. Currently, immunohistochemistry is used to detect normal follicles, sclerosing stromal tumors, granulosa cell tumors, and fibromas/thecomas. Our research results showed that transcription factor enhancer 3 (TFE3) was moderate to strong positive in the theca interna layer of normal follicles. TFE3 was expressed in seven out of eight sclerosing stromal tumors, mainly in luteinized cells. It did not express in 20 granulosa cell tumors. Of the nine fibromas/thecomas, TFE3 was weakly staining in 2 cases and negative in the remaining 7 cases. The expression of TFE3 was also weak in only one microcystic stromal tumor. 8 cases of sclerosing stromal tumors were analyzed by FISH using a TFE3 separation probe, and the results were negative. In short, as a nuclear transcription protein, TFE3 specifically expressed in sclerosing stromal tumors and could serve as a new marker for the diagnosis and differential diagnosis of sclerosing stromal tumors. Moreover, we speculate that TFE3 will promotes the formation of the vascular plexus after entry into the nucleus, which can further explain why sclerosing stromal tumors are different from other ovary sex-cord stromal tumors.
Funder
The Youth Fund of the Third Affiliated Hospital of Guangzhou Medical University in China
Guangdong Natural Science Foundation
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference41 articles.
1. Irving JA, Young RH. Microcystic stromal tumor of the ovary: report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol. 2009;33(3):367–75.
2. Chalvardjian A, Scully RE. Sclerosing stromal tumours of the ovary. Cancer. 1973;31:664–70.
3. Kaygusuz EI, Cesur S, Cetiner H, et al. Sclerosing stromal tumor in young women: clinicopathologic and immunohistochemical spectrum. J Clin Diagn Res. 2013;7:1932–5.
4. Özdemir Ö, Sarı ME, Şen E, et al. Sclerosing stromal tumor of the ovary: a case report and the review of literature. Niger Med J. 2014;55:432–7.
5. Zhao Z, Yan L, Lv H, Liu H, Rong F. Sclerosing stromal tumor of the ovary in a postmenopausal woman with estrogen excess: a case report. Medicine (Baltimore). 2019;98:47.